The following Life Sciences Q&A provides comprehensive and up to date legal information covering:
A clear separation should be maintained between medical and commercial teams. No sales personnel should ever be involved in the delivery of scientific information that could be interpreted as off-label promotion. Medical personnel should, however, be involved in the training of commercial staff and in the review of commercial messaging to ensure its medical accuracy and completeness.
'Advertising' (ie, promotion) of pharmaceutical products is defined in Article 86(1) of Directive 2001/83/EC (consolidated version 26.07.2019), the Pharmaceutical Code as: ‘any form of door-to-door information, canvassing activity or inducement designed to promote the prescription, supply, sale or consumption of medicinal products’. Article 87 of Directive 2001/83/EC (consolidated version 26.07.2019), the Pharmaceutical Code requires that all parts of the advertising of a medicinal product must comply with the particulars listed in the summary of product characteristics (the SMPC). Consequently, any advertising that is not in line with the SMPC (ie, 'off-label') is prohibited. This principle is reinforced in industry self-regulatory codes of conduct, namely the European Federation of Pharmaceutical Industries and Associations (EFPIA) Code on the Promotion of Prescription-only Medicine to and Interactions with, Healthcare Professionals (EFPIA Code) and the Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the Pharmaceutical Industry (ABPI Code).
It is accepted in the EU that not all messages delivered by
**Trials are provided to all LexisPSL and LexisLibrary content, excluding Practice Compliance, Practice Management and Risk and Compliance, subscription packages are tailored to your specific needs. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Take a free trial
This Practice Note examines why parties involved in a construction project may enter into an escrow agreement (or escrow deed) to set up an escrow account. It looks at the benefits of paying funds into escrow, how an escrow account operates and the provisions typically found in an escrow
This Practice Note provides guidance on claims for ‘use and occupation’ or mesne profits, and how and when double rent or double value can be claimed.Claims for use and occupationA claim for use and occupation is possible where there is occupation of land without an express agreement fixing the
BREXIT: As of 31 January 2020, the UK is no longer an EU Member State, but has entered an implementation period during which it continues to be treated by the EU as a Member State for many purposes. As a third country, the UK can no longer participate in the EU’s political institutions, agencies,
This Practice Note discusses the common law doctrine of privity of contract; the equitable and statutory exceptions to it; how the doctrine affects enforcing a contract against a third party and what happens when, notwithstanding the lack of privity, a contract has an indirect effect on a third
0330 161 1234
To view our latest legal guidance content,sign-in to Lexis®PSL or register for a free trial.